ALLAN L. GOLDSTEIN

Insider Reports History

Signature
/s/ Andrew Nick as attorney-in-fact for Allan Goldstein pursuant to a power of attorney filed previously.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ALLAN L. GOLDSTEIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERX BIOPHARMACEUTICALS INC Director Common Stock 1,507,793 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Stock Option (Right to Buy) 480,000 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Convertible Promissory Note (right to buy) 10,440 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Common Stock Warrant (right to buy) 0 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Series A Common Stock Warrant (right to buy) 0 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Series B Common Stock Warrant (right to buy) 0 17 May 2022 Direct

Insider Reports Filed by ALLAN L. GOLDSTEIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000143774922013098-goldstein-allan-l-2022-05-17 REGENERX BIOPHARMACEUTICALS INC 17 May 2022 1 $0 4 Director 19 May 2022, 17:11
/report/000143774922005012-goldstein-allan-l-2021-12-08 REGENERX BIOPHARMACEUTICALS INC 08 Dec 2021 1 $0 4 Director 02 Mar 2022, 15:08
/report/000091419021000206-goldstein-allan-l-2021-08-02 REGENERX BIOPHARMACEUTICALS INC 02 Aug 2021 1 $0 4 Director 04 Aug 2021, 16:10
/report/000091419021000192-goldstein-allan-l-2021-06-30 REGENERX BIOPHARMACEUTICALS INC 30 Jun 2021 3 +$25,000 4 Director 06 Jul 2021, 16:34